Cathepsin Activatable Fluorescent Probe (LUM015)

Clinical Trial ID NCT01626066

Rank	Title	Journal	Year	PubWeight™‹?›
1	The status of contemporary image-guided modalities in oncologic surgery.	Ann Surg	2015	0.97
2	Prospective trial with optical molecular imaging for percutaneous interventions in focal hepatic lesions.	Radiology	2014	0.88
3	A mouse-human phase 1 co-clinical trial of a protease-activated fluorescent probe for imaging cancer.	Sci Transl Med	2016	0.87
4	Imaging primary mouse sarcomas after radiation therapy using cathepsin-activatable fluorescent imaging agents.	Int J Radiat Oncol Biol Phys	2013	0.84
5	A Bright Future for Precision Medicine: Advances in Fluorescent Chemical Probe Design and Their Clinical Application.	Cell Chem Biol	2016	0.84
6	Tailoring Adjuvant Radiation Therapy by Intraoperative Imaging to Detect Residual Cancer.	Semin Radiat Oncol	2015	0.78
7	A Fluorescence-Guided Laser Ablation System for Removal of Residual Cancer in a Mouse Model of Soft Tissue Sarcoma.	Theranostics	2016	0.78
8	Fluorescent nanoparticle imaging allows noninvasive evaluation of immune cell modulation in esophageal dysplasia.	Mol Imaging	2014	0.78
9	A Novel Imaging System Distinguishes Neoplastic from Normal Tissue During Resection of Soft Tissue Sarcomas and Mast Cell Tumors in Dogs.	Vet Surg	2016	0.75
10	Pilot Clinical Trial of Indocyanine Green Fluorescence-Augmented Colonoscopy in High Risk Patients.	Gastroenterol Res Pract	2016	0.75
11	Image-Guided Tumor Resection.	Cancer J	2015	0.75